Stock exchanges & markets

Overview Watchlists

Oracle, AstraZeneca Partner to Explore AI for Clinical Trial Recruitment

8 hours ago

(AWP Alliance News) - Oracle entered a nonbinding agreement with AstraZeneca to explore AI-enabled healthcare applications aimed at improving clinical trial recruitment. The collaboration would combine AstraZeneca's scientific expertise with Oracle's health data, cloud and AI capabilities to help clinicians identify eligible patients sooner.

The companies also plan to use insights from clinical research and routine care to accelerate evidence generation and inform patient care. Initial work could span cancer, rare diseases and other major disease areas.

https://www.publicnow.com/view/F0A4B11F2D1E6CE3E3DD9203ABA8044FE39ED49E…

Disclaimer: This news brief was created using generative artificial intelligence. Oracle Corporation published the original content used to generate this news brief on October 20, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • Compare ETFs systematically

    ETF Compass

    Find the products that suit your investment goals.

    Try the ETF Compass

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now